Science Explorer Back to mapMap
Discussion
Researcher · Vanderbilt University Medical Center · United States

Douglas Buckner Johnson

Douglas Buckner Johnson publishes mostly in Oncology, Molecular Biology and Immunology, on topics such as Cancer Immunotherapy and Biomarkers, Melanoma and MAPK Pathways and CAR-T cell therapy research.

ORCID 0000-0002-6390-773X OpenAlex
World rank
#11,898
of 7,710,434 ranked researchers
Rank in United States
#4,127
of 1,627,098
Works
751
Citations
50k
Citations per work
65.9
h-index
101
i10-index 305Top 0.3% in Oncology
Douglas Buckner Johnson

What does Douglas Buckner Johnson research?

Douglas Buckner Johnson's work is mostly in Medicine (53%), Biochemistry, Genetics and Molecular Biology (16%), Immunology and Microbiology (9%).

Health Sciences: 399 works · 53.1% of their workMedicine: 399 works · 53.1% of their workOncology: 347 works · 46.2% of their workPulmonary and Respiratory Medicine: 35 works · 4.6% of their workEpidemiology: 17 works · 2.3% of their workLife Sciences: 189 works · 25.2% of their workBiochemistry, Genetics and Molecular Biology: 122 works · 16.3% of their workMolecular Biology: 104 works · 13.9% of their workCancer Research: 18 works · 2.4% of their workImmunology and Microbiology: 67 works · 8.9% of their workImmunology: 67 works · 8.9% of their workEverything else: 163 works · 21.7% of their workTHEIR WORKDouglas BucknerJohnson751works
Life Sciences25%Health Sciences53%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine39953.1%
    1. Biochemistry, Genetics and Molecular Biology12216.3%
    2. Immunology and Microbiology678.9%
  3. Everything else16321.7%
  1. 1Oncology46% of their works
  2. 2Molecular Biology14% of their works
  3. 3Immunology9% of their works
  4. 4Pulmonary and Respiratory Medicine5% of their works
  5. 5Cancer Research2% of their works
  6. 6Epidemiology2% of their works

Research topics

Which keywords describe Douglas Buckner Johnson's research?

The keywords of their largest research topics: Immune Checkpoint Blockade, PD-1 and PD-L1, Melanoma, Immunotherapy, Cancer Immunotherapy, BRAF gene, MAP Kinase and CAR T Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Immune Checkpoint Blockade3331 topic
  2. PD-1 and PD-L13331 topic
  3. Melanoma2902 topics
  4. Immunotherapy2783 topics
  5. Cancer Immunotherapy2192 topics
  6. BRAF gene1671 topic
  7. MAP Kinase1671 topic
  8. CAR T Cells1281 topic
  9. Chimeric Antigen Receptor1281 topic
  10. Dermoscopy1231 topic
  11. Skin Cancer1231 topic
  12. Dendritic Cells911 topic
  13. Immunity911 topic
  14. Cetuximab481 topic
  15. KRAS Mutations481 topic
  16. Cancer Genomics371 topic
  17. Mutational Signatures371 topic
  18. Brain Metastases271 topic
  19. Radiosurgery271 topic

Where does Douglas Buckner Johnson work?

Douglas Buckner Johnson's main affiliation in the publication record is Vanderbilt University Medical Center, United States.

How many publications and citations does Douglas Buckner Johnson have?

OpenAlex counts 751 works and 49,505 citations for Douglas Buckner Johnson, an h-index of 101, ranking #11,898 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Douglas Buckner Johnson. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.